Evaluation of programmed cell death protein 1 (PD-1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

Evaluation of programmed cell death protein 1 (PD-1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma

Published:2018-01-10 Issue:4 Volume:7 Page:e1413519
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Kim Kyu Seo¹,Sekar Rishi R.¹,Patil Dattatraya¹²,Dimarco Michelle A.¹³,Kissick Haydn T.¹²⁴⁵,Bilen Mehmet A.⁶⁷,Osunkoya Adeboye O.¹²³⁶,Master Viraj A.¹²⁶

Affiliation:

1. School of Medicine, Emory University, Atlanta, GA, United States

2. Department of Urology, Emory University, Atlanta, GA, United States

3. Department of Pathology, Emory University, Atlanta, GA, United States

4. Department of Microbiology & Immunology, Emory University, Atlanta, GA, United States

5. Emory Vaccine Center, Atlanta, GA, United States

6. Winship Cancer Institute, Atlanta, GA, United States

7. Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, United States

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1413519

Reference50 articles.

1. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

2. High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma

3. Presence of Intratumoral Neutrophils Is an Independent Prognostic Factor in Localized Renal Cell Carcinoma

4. Impact of Immune Parameters on Long-Term Survival in Metastatic Renal Cell Carcinoma

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD1/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives;Molecular Cancer;2024-07-16

2. PD-L1 expression and its prognostic value in metastatic papillary renal cell carcinoma: Results from a GETUG multicenter retrospective cohort;European Journal of Cancer;2024-07

3. Relationships between intravoxel incoherent motion parameters and expressions of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) in patients with cervical cancer;Clinical Radiology;2024-02

4. Pathological Findings Directing Immunotherapy in Renal Cell Carcinomas;Immunotherapy;2024-01-12

5. EXPRESSION OF PROGRAMMED CELL DEATH PROTEIN 1 (PD-1) AND ITS LIGAND PD-L1 IN HIGH-GRADE SEROUS OVARIAN CANCER;Ulyanovsk Medico-biological Journal;2023-09-29